Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Core LaboratoriesMEX:CLB 62 EV-to-EBIT is 13.21 as of Jul. 23, 2026, which is 49% below its 10-year median of 25.94. GuruFocus rates MEX:CLB with a GF Score™ of 62/100 and a GF Value™ of MXN1,282.42. The stock has 3 warning signs investors should review. Among 692 Oil & Gas companies, Core Laboratories ranks worse than 54.48% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Core Laboratories's Enterprise Value for the quarter that ended in Mar. 2026 was MXN42,163 Mil.
Core Laboratories's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN991 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Core Laboratories EV-to-EBIT Related Terms
Core Laboratories EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Core Laboratories's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Oil & Gas Equipment & Services subindustry, Core Laboratories's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Core Laboratories EV-to-EBIT vs Oil & Gas Industry
For the Oil & Gas industry and Energy sector, Core Laboratories's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Core Laboratories's EV-to-EBIT falls into.
Core Laboratories's current Enterprise Value is MXN13,094 Mil.
Core Laboratories's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN991 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Core Laboratories (MEX:CLB) has a EV-to-EBIT of 13.21 as of Jul. 23, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Core Laboratories and its competitors. This is 49% below median its historical median of 25.94. According to the industry distribution chart, Core Laboratories ranks #377 out of 692 companies in the Oil & Gas industry, placing it in the top 54.5%.
Is Core Laboratories' EV-to-EBIT too high?
Core Laboratories' current EV-to-EBIT of 13.21 is 49% below median its 10-year median of 25.94. The Oil & Gas industry median EV-to-EBIT is 11.87. Core Laboratories' value of 13.21 is 11.3% above this industry median. Based on the distribution chart, Core Laboratories ranks #377 out of 692 companies in the Oil & Gas industry, which is below the industry midpoint. Overall, Core Laboratories has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Core Laboratories' EV-to-EBIT compare to EROK and OIS?
According to the Oil & Gas industry distribution chart, Core Laboratories ranks #377 out of 692 companies for EV-to-EBIT. This places Core Laboratories in the lower half of its industry. The industry median EV-to-EBIT is 11.87. Core Laboratories' value of 13.21 is 11.3% above this benchmark. While the company's 10-year median is 25.94 vs. the industry median of 11.87, Core Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for an Oil & Gas company?
The median EV-to-EBIT among Oil & Gas companies is 11.87, based on 692 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Core Laboratories's current EV-to-EBIT of 13.21 is 11.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Core Laboratories and its competitors. For the Oil & Gas industry, the median EV-to-EBIT is 11.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Core Laboratories's current EV-to-EBIT is 13.21, which is 49% below median its own 10-year median of 25.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Core Laboratories stock overvalued right now?
Core Laboratories (MEX:CLB) has a current EV-to-EBIT of 13.21. The stock's GF Value™ is MXN1,282.42, compared to a current price of MXN856.38 — trading 33.2% below its estimated fair value. The current EV-to-EBIT is 13.21, which is 49% below median its 10-year median of 25.94 and 11.3% above the Oil & Gas industry median of 11.87. Core Laboratories' overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Core Laboratories (MEX:CLB), the current EV-to-EBIT is 13.21 as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Core Laboratories (MEX:CLB) Overvalued in 2026?
Based on GuruFocus' analysis, Core Laboratories stock appears to be undervalued.
The current stock price of MXN856.38 is trading 33.2% below its estimated GF Value™ of MXN1,282.42.
Key valuation signals for MEX:CLB:
EV-to-EBIT: 13.21 (49% below median its 10-year median of 25.94)
GF Value™: MXN1,282.42 vs. price of MXN856.38 (33.2% below fair value)
Industry Position: 11.3% above the Oil & Gas median (#377 of 692)
No single metric tells the full story. See the MEX:CLB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.
62GF Score
Get the complete analysis for MEX:CLB
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:CLB has been successfully added to your 
